| Baseline visit | Before 8 week visit | At 8 week visit | After 8 week visit | Final visit at 20-weeks |
---|---|---|---|---|---|
Basic demographics | x | Â | Â | Â | Â |
Medication | x | Â | x | Â | x |
Co-morbidity | x | Â | Â | Â | Â |
Clinical measures | Â | Â | Â | Â | Â |
Weight | x | Â | Â | Â | x |
Blood pressure | x | Â | Â | Â | x |
HbA1c (Central laboratory) | x | Â | x | Â | x |
Adherence | Â | Â | Â | Â | Â |
Electronic medication monitor for preceding period | Â | Â | x (50%) | Â | x |
Self-report (MARS) Diabetes | Â | x | Â | Â | x |
Drug concentrations | Â | Â | x | Â | x |
Psychological | Â | Â | Â | Â | Â |
TPB†Direct measures and intention | x | x |  | x |  |
TPB†Indirect measures | x | x |  | x |  |
Time and location of taking medicines | Â | Â | Â | Â | x |
Communication with practice nurse | Â | Â | Â | Â | x |
Quality of Life | Â | Â | Â | Â | Â |
Short-Form 12‡ | x |  |  |  | x |
Diabetes Treatment Satisfaction Questionnaire | Â | Â | Â | Â | x |
Hypoglycaemia | Â | Â | x | Â | x |